Application no. and date | 02743024.8 (espacenet) (Federated) (European Patent Register), 20020515 | Patent/reg. no. and date | DK/EP 1392313, 20070418 | Publication date | 20040303 | Priority no. and date | US 291427 P, 20010516 | EP pub. no. and date |
EP 1392313 20040303 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 129699 | Inventor | WARTMANN, Markus, Kornfeldstrasse 14
CH-4125 Riehen, CH, BRUNS, Christian, Ziegelhofstrasse 120
79110 Freiburg, DE, BUCHDUNGER, Elisabeth, Saegeweg 13
79395 Neuenburg, DE, O'REILLY, Terence, Drahtzugstrasse 51
CH-4057 Basel, CH, SILBERMAN, Sandra, Leta, 10 Heather Lane
Randolph, NJ 07869, US, WECKBECKER, Gisbert, Löliring 31
CH-4105 Biel-Benken, CH | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61K 31/675 (2006.01) , A61P 35/00 (2006.01) , A61P 37/06 (2006.01) | Title | Kombination omfattende N-{5-[4-(4-methyl-piperazino-methyl)-benzoyl-amido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidin-amin og et biphosphonat | Int. application no. | EP2002005362 | Int. publication no. | WO2002092091 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|